Resmed (RMD) Earnings (2009 - 2026)
Resmed (RMD) earnings from Sep 30, 2009 to Mar 31, 2026. The TTM Resmed (RMD) earnings is $1.52B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Resmed (RMD) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +15.71% |
| 3 Years TTM | +20.76% |
| 5 Years TTM | +27.15% |
| 10 Years TTM | +15.59% |
| All Time TTM | +13.81% |
Annual Earnings change of Resmed (RMD)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $399M | -71.53% |
| 2025 | $1.40B | +37.20% |
| 2024 | $1.02B | +13.75% |
| 2023 | $898M | +15.15% |
| 2022 | $779M | +64.26% |
| 2021 | $475M | -23.67% |
| 2020 | $622M | +53.65% |
| 2019 | $405M | +28.20% |
| 2018 | $316M | -7.80% |
| 2017 | $342M | -2.87% |
| 2016 | $352M | -0.14% |
| 2015 | $353M | +2.21% |
| 2014 | $345M | +12.42% |
| 2013 | $307M | +20.51% |
| 2012 | $255M | +12.27% |
| 2011 | $227M | +19.41% |
| 2010 | $190M | +29.80% |
| 2009 | $146M | N/A |
Comparison Resmed (RMD) five years earnings CAGR with competitors
Resmed (RMD) five years earnings CAGR is 27.15%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| MMSI | Merit Medical Systems Inc | 100.79% | +271.25% |
| POCI | Precision Optics Corp Inc | 83.62% | +207.98% |
| OSUR | Orasure Technologies Inc | 81.42% | +199.88% |
| SMTI | Sanara MedTech Inc | 54.72% | +101.54% |
| GCTK | GlucoTrack Inc | 48.38% | +78.18% |
| NYXH | Nyxoah SA | 41.25% | +51.94% |
| STXS | Stereotaxis Inc | 28.42% | +4.69% |
| RGNT | Regentis Biomaterials Ltd | 26.99% | -0.57% |
| ZTEK | Zentek Ltd | 21.91% | -19.30% |
| XRAY | DENTSPLY Sirona Inc | 21.23% | -21.79% |
| LMAT | Lemaitre Vascular Inc | 21.08% | -22.34% |
| ISRG | Intuitive Surgical Inc | 20.48% | -24.55% |
| HBIO | Harvard Bioscience Inc | 19.81% | -27.03% |
| PDEX | Pro-Dex Inc (co) | 14.33% | -47.20% |
| RGEN | Repligen Corp | 10.68% | -60.65% |
| ATR | Aptargroup Inc | 9.76% | -64.06% |
| MBOT | Microbot Medical Inc | 8.73% | -67.84% |
| PLSE | Pulse Biosciences Inc | 5.66% | -79.15% |
| NXGL | Nexgel Inc | 5.49% | -79.78% |
| STVN | Stevanato Group Spa | 5.39% | -80.14% |
| WST | West Pharmaceutical Services Inc | 5.10% | -81.20% |
| UTMD | Utah Medical Products Inc | 0.83% | -96.94% |